Innospec Inc. (NASDAQ:IOSP – Get Free Report) SVP David Jones sold 1,028 shares of the company’s stock in a transaction on Tuesday, March 3rd. The stock was sold at an average price of $75.64, for a total transaction of $77,757.92. Following the sale, the senior vice president directly owned 14,693 shares of the company’s stock, valued at approximately $1,111,378.52. This trade represents a 6.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Innospec Price Performance
NASDAQ:IOSP opened at $74.22 on Friday. The business’s 50-day moving average is $80.97 and its two-hundred day moving average is $79.03. The firm has a market capitalization of $1.84 billion, a PE ratio of 15.86, a price-to-earnings-growth ratio of 2.03 and a beta of 0.90. Innospec Inc. has a 12 month low of $70.10 and a 12 month high of $102.25.
Innospec (NASDAQ:IOSP – Get Free Report) last posted its earnings results on Tuesday, February 17th. The specialty chemicals company reported $1.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.24. The business had revenue of $455.60 million during the quarter, compared to analyst estimates of $460.87 million. Innospec had a return on equity of 10.18% and a net margin of 6.56%.The company’s revenue for the quarter was down 2.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.41 earnings per share. Equities analysts anticipate that Innospec Inc. will post 6.18 EPS for the current year.
Analyst Ratings Changes
Read Our Latest Report on Innospec
Institutional Inflows and Outflows
A number of large investors have recently bought and sold shares of IOSP. Western Standard LLC increased its holdings in shares of Innospec by 894.0% in the 4th quarter. Western Standard LLC now owns 268,367 shares of the specialty chemicals company’s stock valued at $20,541,000 after acquiring an additional 241,367 shares during the last quarter. Medina Value Partners LLC bought a new position in Innospec during the third quarter worth $18,206,000. Goldman Sachs Group Inc. boosted its holdings in Innospec by 71.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 484,968 shares of the specialty chemicals company’s stock worth $37,119,000 after purchasing an additional 202,325 shares during the period. Millennium Management LLC increased its stake in Innospec by 8,176.5% during the first quarter. Millennium Management LLC now owns 170,414 shares of the specialty chemicals company’s stock valued at $16,147,000 after purchasing an additional 168,355 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Innospec during the fourth quarter worth $10,654,000. Institutional investors own 96.64% of the company’s stock.
Innospec Company Profile
Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.
See Also
- Five stocks we like better than Innospec
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- 1,500 Banks Just Handed the Fed Your Bank Account
- Elon Musk’s $1 Quadrillion AI IPO
- [How To] Invest Pre-IPO In SpaceX With $100!
Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.
